hearing loss Archives

In Depth 20 Jun 2025

Stem cell therapy: a potential cure for hearing loss?

As stem cell research gains momentum, researchers are looking at ways to use the therapy to treat hearing loss.

June 20, 2025 - 13 minutesmins - By Roohi Mariam Peter

In Depth 25 Dec 2024

When biotech makes Christmas miracles a reality

Explore how biotech breakthroughs in 2024 have changed lives, bringing real Christmas miracles to patients and offering hope for the future.

December 25, 2024 - 8 minutesmins - By Jules Adam

Podcast 31 May 2024

Can cell therapy tackle hearing loss

Hearing loss is a growing global challenge. UK-based Rinri Therapeutics is developing a portfolio of off-the-shelf regenerative cell therapy products to address sensorineural hearing loss.

May 31, 2024

Best in Biotech 29 Feb 2024

6 biotech companies making a difference in pediatric care

Take a closer look at six pediatric companies taking innovative approaches to tackle illnesses affecting children.

February 29, 2024 - 8 minutesmins - By Willow Shah-Neville

News and Trends 1 Feb 2024

Can gene therapy be the key to restoring hearing loss?

Explore gene therapy’s success in treating genetic hearing loss as a child regains hearing at the Children’s Hospital of Philadelphia.

February 1, 2024 - 7 minutesmins - By Roohi Mariam Peter

Best in Biotech 30 Aug 2023

Five North Carolina biotech companies making their mark

North Carolina is home to Research Triangle Park, an R&D sanctuary situated between the cities of Raleigh and Durham, which just happens to be one of the biggest biotech hubs in the U.S., with a multitude of renowned companies. The southeastern state even rivals the likes of Boston, San Francisco, Los Angeles, and San Diego, […]

August 30, 2023 - 5 minutesmins - By Willow Shah-Neville

News and Trends 6 Jul 2023

Positive data from Sensorion hearing loss study

Sensorion, which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, has reported further analysis from its Proof of Concept (POC) phase 2a clinical trial of SENS-401 for residual hearing preservation in adult patients following cochlear implantation. In June 19, Sensorion announced that in preliminary […]

July 6, 2023 - 3 minutesmins - By Jim Cornall

Best in Biotech 29 Mar 2023

5 hearing loss biotech companies you should know about

More than 1.5 billion people – nearly 20% of the world’s population – live with hearing loss globally, with 430 million suffering from disabling hearing loss. In this article, we take a look at five of the top hearing loss companies making efforts to reduce these figures. According to the World Health Organization (WHO), nearly […]

March 29, 2023 - 7 minutesmins - By Willow Shah-Neville

Best in Biotech 23 Mar 2023

Hearing loss research: Five advancements in the past year

At present, more than 1.4 billion people live with hearing loss globally. Hearing disorders are often caused by aging, frequent exposure to loud noises and even hereditary factors. In this article, we will look at some of the latest advancements in hearing disorders research which could broaden the scope for treatments and other measures to […]

March 23, 2023 - 8 minutesmins - By Roohi Mariam Peter

News and Trends 31 Jan 2023

Sensorion and EVEON collaborating on injection system to deliver gene therapy inner ear treatments

Sensorion and EVEON are collaborating on the design and development of an injection system for the delivery of Sensorion’s gene therapy products to the inner ear. Therapies for treating genetic hearing loss are often challenging due to the need for delivery into the inner ear, a very small and delicate organ embedded in the temporal […]

January 31, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 3 Jan 2023

Sensorion announces first patient enrolled in cisplatin-induced ototoxicity trial

Sensorion has announced that the first patient has been enrolled in its phase 2a proof of concept clinical trial of SENS-401 (Arazasetron) in patients suffering from cisplatin-induced ototoxicity. Cisplatin and other platinum-based compounds are essential chemotherapeutic agents for many cancers. A serious side effect of these therapies is ototoxicity, or permanent and irreversible hearing loss, […]

January 3, 2023 - 3 minutesmins - By Jim Cornall

More News! 7 Nov 2022

Sensorion granted rare pediatric disease designation by FDA for lead therapy gene

Sensorion has announced that the US Food and Drug Administration (FDA) has granted rare pediatric disease designation to its lead therapy gene candidate, OTOF-GT. The gene therapy is intended for the treatment of otoferlin gene mediated hearing loss. Sensorion’s OTOF-GT gene therapy development program aims to restore hearing in people living with otoferlin deficiency, one […]

November 7, 2022 - 2 minutesmins - By Liza Laws

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

hearing loss

Stem cell therapy: a potential cure for hearing loss?

When biotech makes Christmas miracles a reality

Can cell therapy tackle hearing loss

6 biotech companies making a difference in pediatric care

Can gene therapy be the key to restoring hearing loss?

Five North Carolina biotech companies making their mark

Positive data from Sensorion hearing loss study

5 hearing loss biotech companies you should know about

Hearing loss research: Five advancements in the past year

Sensorion and EVEON collaborating on injection system to deliver gene therapy inner ear treatments

Sensorion announces first patient enrolled in cisplatin-induced ototoxicity trial

Sensorion granted rare pediatric disease designation by FDA for lead therapy gene

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!